Analysis of vasodilator responses to novel nitric oxide donors in the hindquarters vascular bed of the cat

Citation
Tj. Bivalacqua et al., Analysis of vasodilator responses to novel nitric oxide donors in the hindquarters vascular bed of the cat, J CARDIO PH, 38(1), 2001, pp. 120-129
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
ISSN journal
01602446 → ACNP
Volume
38
Issue
1
Year of publication
2001
Pages
120 - 129
Database
ISI
SICI code
0160-2446(200107)38:1<120:AOVRTN>2.0.ZU;2-I
Abstract
Controlled release of nitric oxide (NO.) may be useful in the treatment of a variety of vascular disorders. NO. donors of the diazeniumdiolate family with different rates of spontaneous NO. release have been synthesized. In t he current study responses to seven diazeniurndiolate NO. donors (DEA/NO., DETA/NO., OXI/NO., PIPERAZI/NO., PROLT/NO., SPER/NO., and SULFI/NO.) were i nvestigated in the hindquarters vascular bed of the cat. Intravenous inject ions of all NO. donors caused dose-dependent decreases in systemic arterial pressure and the rank order of potency was SNP > DEA/NO. > PIPERAZI/NO. > SPER/NO. > PROLI/NO. > OXI/NO., Injections of all NO. donors into the hindl imb perfusion circuit caused dose-related decreases in hindquarters perfusi on pressure that were similar to the order of potency in decreasing systemi c arterial pressure. The rank order of the time required for the response t o return to 50% of the maximal decrease in pressure (T-1/2) and total durat ion of action of the NO. donors was SPER/NO. > PIPERAZI/NO. > DEA/NO. > OXV NO. > DETA/NO. > PROLI/NO. > SULFI/NO.. After treatment with the NO. syntha se inhibitor, N-omega-nitro-L-arginine methyl ester (100 mg/kg, i.v.), hind limb vasodilator responses to the NO. donors were not significantly differe nt, but vasodilator responses to acetylcholine were significantly reduced. After treatment with zaprinast (2 mg/kg, i.v.), a type V cyclic 3 ', 5 ' -g uanosine monophosphate-specific phosphodiesterase inhibitor, the duration o f vasodilator responses to the NO. donors, as measured by T-1/2, was increa sed significantly, whereas the duration of the response to the beta (2)-adr energic receptor agonist albuterol was unchanged. These data suggest that d iazeniumdiolate NO. donors are endothelium-independent, directly stimulate soluble guanylate cyclase, and decrease vascular resistance by increasing c yclic 3 ', 5 ' -guanosine monophosphate levels in the hindquarters vascular bed of the cat.